Click for best price
NonAlcoholic Steatohepatitis Treatment Market Size, Share 2023
Nonalcoholic steatohepatitis (NASH) is?inflammation of your liver caused by excess fat cells in it (fatty liver disease). Chronic inflammation causes progressive liver damage. NASH resembles hepatitis caused by alcohol use, but it stems from something else.
This report aims to provide a comprehensive presentation of the global market for Non-Alcoholic Steatohepatitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Alcoholic Steatohepatitis Treatment. This report contains market size and forecasts of Non-Alcoholic Steatohepatitis Treatment in global, including the following market information:
Global Non-Alcoholic Steatohepatitis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Non-Alcoholic Steatohepatitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Vitamin E and Pioglitazone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-Alcoholic Steatohepatitis Treatment include Intercept Pharmaceuticals, Galmed Pharmaceuticals, Inventiva Pharma, AbbVie Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals, NGM Biopharmaceuticals Inc., Novo Nordisk A/S and Bristol Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-Alcoholic Steatohepatitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Alcoholic Steatohepatitis Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Non-Alcoholic Steatohepatitis Treatment Market Segment Percentages, by Type, 2022 (%)
Vitamin E and Pioglitazone
Obeticholic Acid (OCA)
Lanifibranor
Semaglutide
Resmetirom
Aramchol
Cenicriviroc
Others
Global Non-Alcoholic Steatohepatitis Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Non-Alcoholic Steatohepatitis Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail & Specialty Pharmacies
Others
Global Non-Alcoholic Steatohepatitis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Non-Alcoholic Steatohepatitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Alcoholic Steatohepatitis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non-Alcoholic Steatohepatitis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Intercept Pharmaceuticals
Galmed Pharmaceuticals
Inventiva Pharma
AbbVie Inc.
Galectin Therapeutics Inc.
Madrigal Pharmaceuticals
NGM Biopharmaceuticals Inc.
Novo Nordisk A/S
Bristol Myers Squibb
Gilead Sciences Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Alcoholic Steatohepatitis Treatment, market overview.
Chapter 2: Global Non-Alcoholic Steatohepatitis Treatment market size in revenue.
Chapter 3: Detailed analysis of Non-Alcoholic Steatohepatitis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Alcoholic Steatohepatitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Non-Alcoholic Steatohepatitis Treatment Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-Alcoholic Steatohepatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Alcoholic Steatohepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Alcoholic Steatohepatitis Treatment Overall Market Size
2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size: 2022 VS 2029
2.2 Global Non-Alcoholic Steatohepatitis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Alcoholic Steatohepatitis Treatment Players in Global Market
3.2 Top Global Non-Alcoholic Steatohepatitis Treatment Companies Ranked by Revenue
3.3 Global Non-Alcoholic Steatohepatitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Non-Alcoholic Steatohepatitis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-Alcoholic Steatohepatitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Non-Alcoholic Steatohepatitis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-Alcoholic Steatohepatitis Treatment Market Size Markets, 2022 & 2029
4.1.2 Vitamin E and Pioglitazone
4.1.3 Obeticholic Acid (OCA)
4.1.4 Lanifibranor
4.1.5 Semaglutide
4.1.6 Resmetirom
4.1.7 Aramchol
4.1.8 Cenicriviroc
4.1.9 Others
4.2 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2024-2029
4.2.3 By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Alcoholic Steatohepatitis Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail & Specialty Pharmacies
5.1.4 Others
5.2 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2024-2029
5.2.3 By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Non-Alcoholic Steatohepatitis Treatment Market Size, 2022 & 2029
6.2 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2024-2029
6.2.3 By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2029
6.3.2 US Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.3.3 Canada Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.3.4 Mexico Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2029
6.4.2 Germany Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.4.3 France Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.4.4 U.K. Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.4.5 Italy Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.4.6 Russia Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.4.8 Benelux Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2029
6.5.2 China Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.5.3 Japan Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.5.4 South Korea Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.5.6 India Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2029
6.6.2 Brazil Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.6.3 Argentina Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2029
6.7.2 Turkey Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.7.3 Israel Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
6.7.5 UAE Non-Alcoholic Steatohepatitis Treatment Market Size, 2018-2029
7 Non-Alcoholic Steatohepatitis Treatment Companies Profiles
7.1 Intercept Pharmaceuticals
7.1.1 Intercept Pharmaceuticals Company Summary
7.1.2 Intercept Pharmaceuticals Business Overview
7.1.3 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.1.4 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.1.5 Intercept Pharmaceuticals Key News & Latest Developments
7.2 Galmed Pharmaceuticals
7.2.1 Galmed Pharmaceuticals Company Summary
7.2.2 Galmed Pharmaceuticals Business Overview
7.2.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.2.4 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.2.5 Galmed Pharmaceuticals Key News & Latest Developments
7.3 Inventiva Pharma
7.3.1 Inventiva Pharma Company Summary
7.3.2 Inventiva Pharma Business Overview
7.3.3 Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.3.4 Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.3.5 Inventiva Pharma Key News & Latest Developments
7.4 AbbVie Inc.
7.4.1 AbbVie Inc. Company Summary
7.4.2 AbbVie Inc. Business Overview
7.4.3 AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.4.4 AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.4.5 AbbVie Inc. Key News & Latest Developments
7.5 Galectin Therapeutics Inc.
7.5.1 Galectin Therapeutics Inc. Company Summary
7.5.2 Galectin Therapeutics Inc. Business Overview
7.5.3 Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.5.4 Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.5.5 Galectin Therapeutics Inc. Key News & Latest Developments
7.6 Madrigal Pharmaceuticals
7.6.1 Madrigal Pharmaceuticals Company Summary
7.6.2 Madrigal Pharmaceuticals Business Overview
7.6.3 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.6.4 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.6.5 Madrigal Pharmaceuticals Key News & Latest Developments
7.7 NGM Biopharmaceuticals Inc.
7.7.1 NGM Biopharmaceuticals Inc. Company Summary
7.7.2 NGM Biopharmaceuticals Inc. Business Overview
7.7.3 NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.7.4 NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.7.5 NGM Biopharmaceuticals Inc. Key News & Latest Developments
7.8 Novo Nordisk A/S
7.8.1 Novo Nordisk A/S Company Summary
7.8.2 Novo Nordisk A/S Business Overview
7.8.3 Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.8.4 Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.8.5 Novo Nordisk A/S Key News & Latest Developments
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Company Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.9.4 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.9.5 Bristol Myers Squibb Key News & Latest Developments
7.10 Gilead Sciences Inc.
7.10.1 Gilead Sciences Inc. Company Summary
7.10.2 Gilead Sciences Inc. Business Overview
7.10.3 Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Major Product Offerings
7.10.4 Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Revenue in Global Market (2018-2023)
7.10.5 Gilead Sciences Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non-Alcoholic Steatohepatitis Treatment Market Opportunities & Trends in Global Market
Table 2. Non-Alcoholic Steatohepatitis Treatment Market Drivers in Global Market
Table 3. Non-Alcoholic Steatohepatitis Treatment Market Restraints in Global Market
Table 4. Key Players of Non-Alcoholic Steatohepatitis Treatment in Global Market
Table 5. Top Non-Alcoholic Steatohepatitis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Non-Alcoholic Steatohepatitis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Non-Alcoholic Steatohepatitis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Non-Alcoholic Steatohepatitis Treatment Product Type
Table 9. List of Global Tier 1 Non-Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Non-Alcoholic Steatohepatitis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Intercept Pharmaceuticals Company Summary
Table 31. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 32. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Intercept Pharmaceuticals Key News & Latest Developments
Table 34. Galmed Pharmaceuticals Company Summary
Table 35. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 36. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Galmed Pharmaceuticals Key News & Latest Developments
Table 38. Inventiva Pharma Company Summary
Table 39. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 40. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Inventiva Pharma Key News & Latest Developments
Table 42. AbbVie Inc. Company Summary
Table 43. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 44. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. AbbVie Inc. Key News & Latest Developments
Table 46. Galectin Therapeutics Inc. Company Summary
Table 47. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 48. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Galectin Therapeutics Inc. Key News & Latest Developments
Table 50. Madrigal Pharmaceuticals Company Summary
Table 51. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 52. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Madrigal Pharmaceuticals Key News & Latest Developments
Table 54. NGM Biopharmaceuticals Inc. Company Summary
Table 55. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 56. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. NGM Biopharmaceuticals Inc. Key News & Latest Developments
Table 58. Novo Nordisk A/S Company Summary
Table 59. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 60. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Novo Nordisk A/S Key News & Latest Developments
Table 62. Bristol Myers Squibb Company Summary
Table 63. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 64. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol Myers Squibb Key News & Latest Developments
Table 66. Gilead Sciences Inc. Company Summary
Table 67. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Product Offerings
Table 68. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Gilead Sciences Inc. Key News & Latest Developments
List of Figures
Figure 1. Non-Alcoholic Steatohepatitis Treatment Segment by Type in 2022
Figure 2. Non-Alcoholic Steatohepatitis Treatment Segment by Application in 2022
Figure 3. Global Non-Alcoholic Steatohepatitis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-Alcoholic Steatohepatitis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-Alcoholic Steatohepatitis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue in 2022
Figure 8. By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 16. US Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 28. China Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Non-Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
